Abzena has appointed Jonathan Goldman, MD as chief executive officer, following completion of the Acquisition by Welsh, Carson, Anderson & Stowe (WCAS).   Dr. Goldman will focus his efforts on the growth of Abzena as the leading provider of outsourced and integrated services in the biologics early development space by establishing new partnerships with clients, building internal manufacturing capacity and pursuing strategic acquisitions. He joins the company after achieving significa...